Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Nichols

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosisScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Plos One|May 5, 2022
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trialSilvia M Caceres, Linda A Sanders, Noel M Rysavy, et al.
Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
ERJ Open Research|December 3, 2025
Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosisGina Hong, Joanna Walsh, Allen Koshy, et al.
Plos One|March 2, 2013
Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survivalKenneth C Malcolm, E Michelle Nichols, Silvia M Caceres, et al.
Thorax|October 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trialDavid P Nichols, Pradeep K Singh, Arthur Baines, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 11, 2025
Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor ProliferationJian Wu, Xiaobei Wang, Parker Mathews, et al.
Plos One|September 9, 2016
Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress SyndromeJerry A Nick, Silvia M Caceres, Jennifer E Kret, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 16, 2023
Effect of elexacaftor/tezacaftor/ivacaftor on mucus and mucociliary clearance in cystic fibrosisScott H Donaldson, Timothy E Corcoran, Joseph M Pilewski, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|November 24, 2018
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosisIsabelle Sermet-Gaudelus, John P Clancy, David P Nichols, et al.
Plos One|May 5, 2022
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trialSilvia M Caceres, Linda A Sanders, Noel M Rysavy, et al.
Annals of the American Thoracic Society|January 19, 2021
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study DesignNicole Mayer-Hamblett, David P Nichols, Katherine Odem-Davis, et al.
ERJ Open Research|December 3, 2025
Home sputum collection for <i>Aspergillus fumigatus</i> detection in adults with cystic fibrosisGina Hong, Joanna Walsh, Allen Koshy, et al.
Plos One|March 2, 2013
Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survivalKenneth C Malcolm, E Michelle Nichols, Silvia M Caceres, et al.
Thorax|October 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for <i>P. aeruginosa</i> in cystic fibrosis: a randomised, controlled clinical trialDavid P Nichols, Pradeep K Singh, Arthur Baines, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 11, 2025
Optimized Monothiol Thioredoxin Derivative (ORP100S) Protects In Vitro and In Vivo from Radiation and Chemotoxicity Without Promoting Tumor ProliferationJian Wu, Xiaobei Wang, Parker Mathews, et al.
Plos One|September 9, 2016
Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress SyndromeJerry A Nick, Silvia M Caceres, Jennifer E Kret, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 4, 2023
Prospective evaluation of nontuberculous mycobacteria disease in cystic fibrosis: The design of the PREDICT studyStacey L Martiniano, Silvia M Caceres, Katie Poch, et al.
Pageof 7